Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Biliary Tract Neoplasms × Taxes × Clear all

Sponsor

Conditions

Breast Neoplasms 47 Fallopian Tube Neoplasms 22 Carcinoma, Non-Small-Cell Lung 21 Ovarian Neoplasms 17 Triple Negative Breast Neoplasms 15 Pancreatic Neoplasms 11 Breast Neoplasms, Male 11 Lung Neoplasms 9 Brenner Tumor 9 Inflammatory Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Melanoma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Adenocarcinoma Of Esophagus 4 Squamous Cell Carcinoma of Head and Neck 3 Pleural Effusion, Malignant 3 Endometrial Adenocarcinoma 3 Cholangiocarcinoma 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Thymoma 2 Pancreatic Adenocarcinoma 2 Neurotoxicity Syndromes 2 Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Breast Carcinoma In Situ 2 Brain Neoplasms 2

Interventions

Gemcitabine 14 Cisplatin 10 Nivolumab 6 pembrolizumab 4 Oxaliplatin 4 Capecitabine 4 trametinib 3 tremelimumab 2 lenvatinib 2 durvalumab 2 derazantinib 2 atezolizumab 2 Ramucirumab 2 Radiofrequency Ablation 2 Fluorouracil 2 Cryosurgery 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tocilizumab 1 telotristat ethyl 1 sargramostim 1 rucaparib 1 regorafenib 1 pertuzumab 1 merestinib 1 irinotecan sucrosofate 1 devimistat 1 dabrafenib 1 cytokine inducible SH2-containing protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡